Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

6over6

Explore full profile

Offers a digital healthcare platform that enables users to perform their own eye vision test

Tel Aviv-Yafo, IsraelFounded 2013Health Tech & Medtech
Valuation $100–250M Last recorded · 2019
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for 6over6 and the history behind them.

About 6over6

6over6 is a technology company revolutionizing the eyewear shopping experience through its suite of digital tools. Operating in the optical retail market, 6over6 serves both online and brick-and-mortar eyewear retailers by providing solutions that enhance customer satisfaction and streamline the purchasing process. The company's core products include GoLenses, an at-home lensometer that allows customers to read their prescription details from their current glasses, GoPD, a tool for measuring pupillary distance (PD) online, and GoFit, a face-scanning tool that provides accurate frame recommendations from the retailer's catalogue. These tools are designed to reduce cart abandonment, increase conversion rates, and create a seamless shopping experience. 6over6 generates revenue through a B2B model, partnering with eyewear retailers who integrate these tools into their sales platforms. By improving the accuracy and convenience of online eyewear shopping, 6over6 helps retailers retain customers and drive sales.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2013
Headquarters
Tel Aviv-Yafo, Israel
Employees
50
Open positions
None listed
Dealroom signal
60.4/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Eyewear, Personal Health, Testing, Ophthalmology, Patient Care, Optical Technology, Spinout, Tech for Patients
Technology
Artificial Intelligence, Deep Tech
Business model
SaaS
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Dec 2019 $100M $100M 1-800 Contacts —
SERIES A✓Equity / VC Sep 2017 $11M $44M Rimonci Capital —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

6over6 website traffic

Latest recorded traffic for 6over6 is 1K monthly website visits, down 88.6% over the last three months. 6over6's team grew 0% over the past year.

Latest monthly visits1K 3-month web change-88.6% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
EyeNetraMobile phone eye diagnostics that measure the correction of users' vision Somerville, United States Operational 8 $5.2M $16M
Pear TherapeuticsPear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need Boston, United States Operational
Empire GenomicsLeader in the field of molecular diagnostic services for oncology diseases Cheektowaga, United States Acquired
EyeYon MedicalDevelops and brings to market exclusive medical ophthalmic devices, which offer relief to the unmet clinical needs of millions of patients Jerusalem, Israel Operational
Multiplicom#Multiplicom is the leading Belgian biotech company that develops, manufactures and commercializes molecular diagnostic tests that enable personalized medicine Antwerp, Belgium Acquired
PreneticsAims to give millions of people personalized information about the health of their bodies to help them confidently make choices about their lives Eastern District, Hong Kong Operational
NeoChordNeoChord, a medical device company, develops devices that allow mitral valve repair to be performed on a beating heart Blackstone, United States Operational
Beyond VerbalBeyond Verbal is committed to identifying proprietary Vocal Biomarkers for personalized healthcare screening & monitoring based on voice Tel Aviv-Yafo, Israel Acquired
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Rimonci Capital

Other known investors2 additional known investors

  • 1-800 Contacts
  • Bar-Ilan University
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇱 Israel100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about 6over6 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See 6over6’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.